PER Podcast Sessions

PER Podcast Sessions

Download on the App Store

All PER Podcast Sessions episodes

  • S2 Ep10: Multidisciplinary Perspectives on Saving Sight—The Expanding Role of the Optometrist in Retinal Disease Care
    Optometrists play a critical role in first-line screening and monitoring of patients with neovascular age-related macular degeneration (or nAMD) and diabetic macular edema (or DME). Where patients require more advanced care, optometrists refer them to retina specialists. Join Drs Ferhina Ali, Carl Regillo, Jessica Steen and Mohammad Rafieetary as they review the role of optometrists in managing retina disease, the role of OCT in the diagnosis and monitoring of retina disease, and the circumstances where patients with retina disease require referral.

    Faculty

    Carl D. Regillo, MD, FACS
    Retina Surgeon
    Philadelphia, PA

    Mohammad Rafieetary, OD
    Charles Retina Institute
    Germantown, TN

    Jessica Steen, OD
    Assistant Professor
    College of Optometry
    Fort Lauderdale, FL

    Ferhina S. Ali, MD, MPH

    New York Medical College
    Valhalla, NY












    28 min
  • S2 Ep9: Clinical Pearls in Co-Managing Glaucoma
    This PER® Spectives™ featured podcast examines the important role of co-management of glaucoma between optometrists and ophthalmologists .Expert faculty review the selection of traditional and novel topical therapies, and also patient selection for micro-incisional glaucoma surgery (MIGS). 


    Faculty

    Danica J. Marrelli, OD, FAAO, AAO 
    College of Optometry, University of Houston
    Houston, TX

    Alena Reznik, MD
    Glaucoma Care Center
    Newport Beach, CA

    13 min
  • S2 Ep8: Advances in Treatment for Geographic Atrophy
    This podcast provides a review of some of the key highlights from the Controversies in Modern Eye Care meeting held in April 2023. The program is designed for those who did not attend the live meeting and to help reinforce learnings for those who did.

    Faculty

    David S. Boyer, MD
    Retina-Vitreous Associates Medical Group
    Los Angeles, CA

    Tina Mac Donald, OD, CDCES, FAAO
    WesternU Health Los Angeles
    Los Angeles, CA

    Leo Semes, OD, FAAO
    The University of Alabama at Birmingham
    Birmingham, AL
    29 min
  • S2 Ep6: Thyroid Eye Disease: The Masquerading Eye Disorder - A Guide to Accurate Diagnosis & Collaborative Care
    In this episode, four expert faculty talk about the importance of early diagnosis and treatment of thyroid eye disease. They discuss the differential diagnosis, screening tests, and the need for multidisciplinary management for these patients.

    Faculty

    Steven Leibowitz, MD
    Associate Clinical Professor, Oculoplastics and Orbit
    Jules Stein Eye Institute
    UCLA School of Medicine
    Los Angeles, CA

    Raymond Douglas, MD, PhD
    Clinical Professor of Ophthalmology
    Jules Stein Eye Institute
    UCLA School of Medicine
    Los Angeles, CA

    Selina McGee OD, FAAO
    CEO/Owner BeSpoke Vision
    President Intrepid Eye Society
    Board of Examiners Oklahoma Optometry
    Edmond, OK

    Terry J. Smith, MD
    Frederick G.L. Huetwell Professor
    Ophthalmology and Visual Sciences
    Professor of Internal Medicine
    University of Michigan Medical School
    Ann Arbor, MI 
    26 min
  • S2 Ep5: Considerations for Customizing Care Plans for Patients with Parkinson Disease Psychosis
    In this podcast, two experts discuss the diagnosis and treatment of Parkinson disease psychosis. In their conversation, they discuss examples of patients they have encountered. They also discuss the results of recent clinical trials of new therapies and the importance of a multispecialty approach for these patients.

    Faculty


    Gus Alva, MD, DFAPA
    Medical Director, Senior Brain Health
    Hoag Hospital
    Assistant Professor of Psychiatry and Neuroscience
    University of California, Riverside
    Medical Director
    ATP Clinical Research
    Costa Mesa, CA

    Stuart Isaacson, MD
    Director
    Parkinson’s Disease and Movement Disorders Center of Boca Raton
    Boca Raton, FL

    31 min
  • S2 Ep4: Catching and Addressing Early Neurotropic Keratitis: New Perspectives
    Neurotrophic keratitis (NK) is a rare condition caused by trigeminal nerve damage, which results in decreased or absent corneal sensitivity and breakdown of the corneal epithelium. If not recognized and managed appropriately, it can lead to corneal ulceration and loss of vision. However, early diagnosis and treatment can improve outcomes.

    This featured podcast includes an interview with an optometrist that highlights key considerations in diagnosing NK at an early stage and treating it with traditional and emerging therapies.


    Faculty

    Walter Whitley, OD, MBA, FAAO
    Director of Professional Relations and Education
    Regional Medical Director - Mid-Atlantic
    EyeCare Partners, LLC
    Norfolk, VA

    15 min
  • S2 Ep3: Facing the Changing Landscape for Neuromodulators and Dermal Fillers
    Thanks for your interest in this podcast. Please read this important program information before listening. Access to the posttest and instructions for claiming credit for participating are included below.
    This PER® Spectives™ podcast examines the recent increase in the demand for dermal fillers and neuromodulators, and the corresponding increase in the number of products available for health care providers to use. In this podcast, faculty member Joshua Zeichner, MD, describes these 2 classes of agents and their uses, alone and in combination. He does this by answering questions that are frequently asked by dermatology health care professionals. 
    Accreditation/Credit Designation
    Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
    Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
    Acknowledgment of Educational Grant Support
    This activity is supported by an educational grant from Galderma.
    Target Audience 
    This activity will be specifically targeted to health care providers (HCPs) who manage neuromodulators and dermal fillers, including dermatologists, aestheticians, nurse practitioners, physician assistants, and registered nurses. Other HCPs involved in the management of facial aesthetics are also invited to participate. 
    Learning Objectives
    Upon successful completion of this activity, you should be better prepared to: 
    · Describe the appropriate use of currently available neuromodulators and dermal fillers for the treatment of facial aging
    · Identify patients who could benefit from a combined treatment approach or novel cosmetic injectable
    Faculty:
    Joshua Zeichner, MD
    Director of Cosmetic and Clinical Research
    Dermatology Department
    Mount Sinai Hospital
    Associate Professor
    Department of Dermatology
    Icahn School of Medicine at Mount Sinai
    New York, NY
    Disclosures: Grant/Research Support: AbbVie, Arcutis, ASLAN, Biofrontera, EPI Health, Galderma, Johnson & Johnson, L’Oréal, Procter & Gamble, Unilever; Consultant: AbbVie, Dermavant, Incyte, Leo Pharma, Pfizer, Sun Pharmaceutical Industries.
    The staff of Physicians’ Education Resource®, LLC, have no relevant financial relationships with ineligible companies.
    PER® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.
    Off-Label Disclosure and Disclaimer
    This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a health care professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.
    Release Date: February 15, 2023 
    Expiration Date:  February 15, 2024
    To claim credit, visit: https://gotoper.com/fclndf23
    25 min
  • S2 Ep2: Addressing Healthcare Inequities™: Tailoring Management Plans to Address Healthcare Disparities in Cystic Fibrosis
    Thanks for your interest in this podcast. Please read this important program information before listening. Access to the post-test and to claim credit for participating is included below.

    This PER® Spectives™ podcast includes a discussion with 3 experts on health disparities that negatively impact patients with cystic fibrosis (CF). Access to care, insurance costs, and unintended bias are just some of the factors that contribute to the existence and persistence of these disparities. This program is designed to help clinicians better recognize and take steps to address ethnic and racial disparities, as well as social and economic inequities, in CF, thereby forwarding progress to improve patient outcomes.

    Accreditation/Credit Designation

    Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Acknowledgment of Educational Grant Support

    This activity is supported by an educational grant from Vertex Pharmaceuticals.

    Target Audience 

    This educational activity is directed toward CF specialists, pulmonologists, pediatricians, gastroenterologists, nurse practitioners, physician assistants, nurses, and other clinicians who provide care for patients with cystic fibrosis.

    Learning Objectives

    Upon successful completion of this activity, you should be better prepared to: 

    • Identify patients who are at risk of CF healthcare disparities
    • Analyze clinical trial data for current and emerging therapies for the treatment of cystic fibrosis
    • Design individualized multidisciplinary management plans for patients with cystic fibrosis who experience healthcare disparities

    Chair:

    Emily DiMango, MD
    Professor of Medicine 
    Director, Adult Cystic Fibrosis Program
    Columbia University Medical Center
    New York, NY

    Disclosures: Grant/Research Support: Vertex Pharmaceuticals. Other Support: Site investigator for clinical trial.

    Faculty:

    Clement L. Ren, MD, MBA
    Professor of Pediatrics 
    University of Pennsylvania Perelman School of Medicine
    Cystic Fibrosis Center Director 
    Children’s Hospital of Philadelphia
    Philadelphia, PA

    Disclosures: Grant/Research Support: Vertex Pharmaceuticals. Consultant: AbbVie, MannKind Corporation, Takeda, Vertex Pharmaceuticals, Vyaire Medical.

    Winsome Sewell, LCSW
    Senior Social Worker 
    Cystic Fibrosis Center 
    Morgan Stanley Children’s Hospital of New York Presbyterian
    New York, NY

    Disclosures:  Winsome Sewell, LCSW has no relevant financial relationships with ineligible companies.

    The staff of Physicians’ Education Resource®, LLC, have no relevant financial relationships with ineligible companies. 

    PER® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.

    Off-Label Disclosure and Disclaimer
    This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a healthcare professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.

    Release Date

    January 30, 2023

    Expiration Date

    January 30, 2024

    https://www.gotoper.com/ahi-fc-podcast

    59 min
  • S2 Ep1: MGD-Associated Dry Eye Disease – How Emerging Options May Shift the Treatment Paradigm
    Meibomian gland dysfunction (MGD) is a complex, multifactorial disorder that can lead to altered tear film composition and ocular surface disease. In fact, MGD is one of the most common causes of dry eye disease (DED). Although multiple treatment options are available, therapies that target the underlying pathophysiology of the disease are lacking. Emerging agents with novel mechanisms for treating MGD may ultimately provide new treatment alternatives.

    This podcast episode provides a review of some of the key highlights from a live symposium held during the American Academy of Optometry Annual Meeting 2022 in October.

    Faculty

    Kelly K. Nichols, OD, MPH, PhD, FAAO
    Dean
    University of Alabama at Birmingham School of Optometry
    Birmingham, AL

    Marc R. Bloomenstein, OD, FAAO
    Director, Optometric Services
    Schwartz Laser Eye Center
    Scottsdale, AZ
    19 min